Zobrazeno 1 - 10
of 196
pro vyhledávání: '"R. Voll"'
Autor:
P. Mertz, M. Piga, E. Chessa, Z. Amoura, R. Voll, A. Schwarting, F. Maurier, G. Blaison, B. Bonnotte, V. Poindron, C. Fiehn, H.M. Lorenz, A.S. Korganow, J. Sibilia, T. Martin, L. Arnaud
Publikováno v:
Revue du Rhumatisme. 89:A221-A222
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N. Frede, E. Rieger, R. Lorenzetti, A. Venhoff, A. M. Kanne, M. Von Deimling, N. Bartholomä, J. Thiel, R. Voll, N. Venhoff
Publikováno v:
Annals of the Rheumatic Diseases. 81:1533.1-1533
BackgroundRespiratory tract infections (RTIs) are the most common infections in patients with rheumatic diseases under immunosuppressive treatment. RTIs may cause significant morbidity with reduced quality of life (QOL), increased healthcare costs an
Autor:
R. Hasseli, B. F. Hoyer, H. M. Lorenz, A. Pfeil, A. Regierer, J. Richter, T. Schmeiser, A. Strangfeld, R. Voll, H. Schulze-Koops, A. Krause, C. Specker, U. Müller-Ladner
Publikováno v:
Annals of the Rheumatic Diseases. 81:957.1-957
BackgroundAt the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) pandemic, the influence of anti-inflammatory therapy on the course of SARS-CoV-2 infection in patients with inflammatory rheumatic
Autor:
R. Hasseli, B. F. Hoyer, H. M. Lorenz, A. Pfeil, A. Regierer, J. Richter, T. Schmeiser, A. Strangfeld, A. Krause, R. Voll, H. Schulze-Koops, U. Müller-Ladner, C. Specker
Publikováno v:
Annals of the Rheumatic Diseases. 81:119-119
BackgroundSARS-CoV-2 vaccines offer the most effective way to reduce the risk of severe COVID-19. Recent data indicate sufficient immune response after vaccination in most patients with inflammatory rheumatic diseases (IRD) on immunomodulatory treatm
Autor:
I. Janowska, J. Korzhenevich, J. Staniek, R. Lorenzetti, L. Konstantinidis, M. Erlacher, P. Schafer, R. Voll, J. Thiel, N. Venhoff, M. Rizzi
Publikováno v:
Annals of the Rheumatic Diseases. 81:456.2-456
BackgroundB differentiation in the bone marrow (BM) is impaired in patients carrying mutation in the IKFZ1 gene, coding for Ikaros a zinc-finger transcription factor. High Ikaros expression is on the contrary associated with systemic lupus erythemato
Autor:
J. Rech, A. Kleyer, M. Østergaard, M. Hagen, L. Valor, K. Tascilar, G. Krönke, V. Schönau, S. Kleinert, X. Baraliakos, J. Braun, M. Fleck, A. Rubbert-Roth, F. Behrens, M. Feuchtenberger, M. Zaenker, D. M. Kofler, R. Voll, C. Glaser, A. Hueber, E. Feist, G. R. Burmester, K. Karberg, J. Strunk, J. D. D. Cañete, L. Šenolt, E. Naredo, G. Schett
Publikováno v:
Annals of the Rheumatic Diseases. 81:526.2-527
BackgroundThe development of RA is described by a preclinical phase of autoimmunity, that precedes clinical disease. This autoimmune phase is characterized by the presence of anti-modified protein antibodies that recognize citrullinated proteins (ACP
Autor:
N. Frede, E. Rieger, R. Lorenzetti, A. Venhoff, C. Hentze, I. Jandova, C. Glaser, J. Thiel, R. Voll, N. Venhoff
Publikováno v:
Annals of the Rheumatic Diseases. 81:1534.3-1535
BackgroundAxial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) may have a profound impact on health-related quality of life (HRQoL) and sleep despite effective treatment.ObjectivesTo assess sleep and HRQoL in SpA and determine associated fac
Publikováno v:
Annals of the Rheumatic Diseases. 81:428.2-429
BackgroundHaemochromatosis arthropathy (HA) is one of the most frequent manifestations of hereditary haemochromatosis (HH). Moreover, frequency of osteoporosis is increased in HH. MicroRNAs (miRNAs) are small non-coding RNAs involved in gene silencin
Autor:
Aurore, Meyer, Aurélien, Guffroy, Gilles, Blaison, Yannick, Dieudonne, Zahir, Amoura, Bernard, Bonnotte, Christoph, Fiehn, Pierre, Kieffer, Hannes Martin, Lorenz, Nadine, Magy-Bertrand, François, Maurier, Jean-Louis, Pennaforte, Hans-Hartmut, Peter, Andreas, Schwarting, Jean, Sibilia, Laurent, Arnaud, Thierry, Martin, Reinhard Edmund, Voll, Anne-Sophie, Korganow, R, Voll
Publikováno v:
Lupus Science & Medicine
Lupus science & medicine
Lupus science & medicine, BMJ, 2020, 7 (1), pp.e000399. ⟨10.1136/lupus-2020-000399⟩
Lupus science & medicine
Lupus science & medicine, BMJ, 2020, 7 (1), pp.e000399. ⟨10.1136/lupus-2020-000399⟩
ObjectiveSystemic lupus is a chronic autoimmune disease characterised by its phenotypic heterogeneity. Neutropaenia is a frequent event in SLE occurring in 20%–40% of patients depending on the threshold value of neutrophil count. On a daily basis,